# Does the Hyoscine N-Butylbromide Administered During Colonoscopy Increase the Adenoma Detection Rate?

> **NCT01609855** · PHASE4 · UNKNOWN · sponsor: **Valduce Hospital** · enrollment: 400 (estimated)

## Conditions studied

- Colonic Adenomas

## Interventions

- **DRUG:** Hyoscine Butyl Bromide 20mg/2 ml i.v.
- **DRUG:** Saline 2 ml i.v.

## Key facts

- **NCT ID:** NCT01609855
- **Lead sponsor:** Valduce Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2012-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01609855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01609855, "Does the Hyoscine N-Butylbromide Administered During Colonoscopy Increase the Adenoma Detection Rate?". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01609855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*